Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

OPEN Health is acquired by Astorg in partnership with Amulet Capital

OPEN Health’s current management team, headed by CEO Rob Barker, will continue to lead the company

Interactive: Best Behaviour

Download our curated collection of case studies and other useful resources that illustrate how we apply the principles of behavioural science in our research design.

Inizio

- PMLiVE

Measurement in Med Comms: Striving for Creative Effectiveness

How to achieve creative success in Med Comms (Article written 6th Jan 2020)

Dice Medical Communications

A person smiling for the cameraDescription automatically generated with medium confidence

Reflections on the MAPS EMEA 2022 Annual Meeting

Amanda Henkel, VP Strategy, Nucleus X Consulting (part of Nucleus Global) shares her thoughts on this year’s meeting.

Nucleus Global

- PMLiVE

Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy

The drug is now approved to treat SMA in children and adults of all ages

- PMLiVE

Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities

The initiative wants to increase the global use of biosimilars by at least 30% by 2030

- PMLiVE

Leipzig/Halle Airport region in Germany joins forces to attract investors

The airport and development agencies sign an extensive cooperation agreement

Relaunch post

Fox&Cat Now Helps All Communications Teams To Thrive Under Pressure

Specialist communications agency fox&cat relaunches today with a refined proposition: to help all communications teams thrive under pressure.  So, whether pressure is being felt in an in-house team, an agency, or...

Fox&Cat

- PMLiVE

Novartis’ Kymriah receives FDA approval to treat follicular lymphoma

The CAR-T cell treatment is approved for adult patients who have had two or more previous therapies

- PMLiVE

NRG Therapeutics receives £2.68m Innovate UK Award

The funds will be used for research into new treatments for Parkinson’s and motor neurone disease

- PMLiVE

Diversity in Pharma: The Impact of COVID-19 on DE&I

COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all...

- PMLiVE

Phase 3 trial initiated to evaluate AZ’s Saphnelo in lupus nephritis

The antibody has already been approved to treat systemic lupus erythematosus

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links